Haleon plc (NYSE:HLN) Short Interest Update

Haleon plc (NYSE:HLN) saw a significant drop in short interest in the month of October. As of October 31st, there was short interest totalling 7,910,000 shares, a drop of 22.8% from the October 15th total of 10,240,000 shares. Based on an average daily volume of 5,230,000 shares, the short-interest ratio is currently 1.5 days. Approximately 0.2% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

HLN has been the subject of several analyst reports. Morgan Stanley upped their target price on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research note on Friday, September 20th. UBS Group raised shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. The Goldman Sachs Group cut Haleon from a “buy” rating to a “neutral” rating in a research note on Tuesday, August 6th. Finally, Berenberg Bank began coverage on Haleon in a research note on Tuesday, August 6th. They set a “buy” rating for the company. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $10.95.

Haleon Price Performance

Shares of HLN stock opened at $9.30 on Friday. The firm has a fifty day moving average of $10.12 and a two-hundred day moving average of $9.33. The firm has a market cap of $42.08 billion, a P/E ratio of 27.34, a P/E/G ratio of 2.80 and a beta of 0.30. Haleon has a 1-year low of $7.89 and a 1-year high of $10.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58.

Institutional Trading of Haleon

Several hedge funds and other institutional investors have recently bought and sold shares of HLN. Fortitude Family Office LLC bought a new position in Haleon during the 3rd quarter worth approximately $28,000. Cultivar Capital Inc. bought a new position in Haleon during the second quarter worth $40,000. Allspring Global Investments Holdings LLC acquired a new position in Haleon in the first quarter worth $43,000. Hexagon Capital Partners LLC increased its stake in Haleon by 66.6% during the second quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company’s stock valued at $55,000 after purchasing an additional 2,677 shares during the last quarter. Finally, Prospera Private Wealth LLC bought a new position in shares of Haleon in the 3rd quarter worth about $57,000. 6.67% of the stock is owned by institutional investors.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.